Feasibility Study CORPPS (FAISA-CORPPS)

University Hospital, Lille

Status: Unknown

Conditions: Laryngeal Neoplasms; Esophageal Neoplasm

Treatments: Device: Digital platform

Study type: Observational

Funder types: Other

Identifiers

NCT05406024

2021-A02644-37 (Other Identifier)

2021_0215

Details and patient eligibility

About

The incidence of cancer in France has increased by +135% to reach nearly 400,000 new cases in 2018. The ten-year cancer control strategy 2021-2030 and the health innovation plan have defined strategic axes. Almost all of these axes are addressed in our project. Firstly, the main objective of our study is to improve the quality of life of patients. Secondly, pharyngolaryngeal and oesophageal cancers are among the cancers with a poor prognosis in adults. Thirdly, the project provides access to personalised supportive care for all patients at all times. Finally, the secondary objectives of this study are the prevention of post-operative complications (infectious, thrombo-embolic, pain...).

Enrollment: 30 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Hospitalized for initial surgical management of esophageal or laryngeal cancer
• Admitted to a conventional ward after partial oesophagectomy or total laryngectomy in a neoplastic setting
• Patient giving consent to participate in the study
• Affiliated to the compulsory health insurance scheme, regardless of the scheme

Exclusion criteria

• Patient who did not follow the previously described course of care prior to admission to the ward
• Esophagectomy with total circular pharyngo-laryngectomy
• Total esogastrectomy
• Illiterate, visually impaired patient
• Minor, or adult under guardianship or curatorship, under judicial protection, person deprived of liberty